Michaela Medová

1.5k total citations
51 papers, 1.0k citations indexed

About

Michaela Medová is a scholar working on Molecular Biology, Oncology and Hepatology. According to data from OpenAlex, Michaela Medová has authored 51 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 16 papers in Oncology and 16 papers in Hepatology. Recurrent topics in Michaela Medová's work include Liver physiology and pathology (15 papers), Cancer, Hypoxia, and Metabolism (12 papers) and Cancer-related Molecular Pathways (11 papers). Michaela Medová is often cited by papers focused on Liver physiology and pathology (15 papers), Cancer, Hypoxia, and Metabolism (12 papers) and Cancer-related Molecular Pathways (11 papers). Michaela Medová collaborates with scholars based in Switzerland, Germany and United States. Michaela Medová's co-authors include Yitzhak Zimmer, Daniel M. Aebersold, Deborah Stroka, Lluís Nisa, Paola Francica, Andree Blaukat, Adrian Keogh, Matúš Medo, Bruno Streit and Daniel Candinas and has published in prestigious journals such as Nature Communications, Cancer Research and Oncogene.

In The Last Decade

Michaela Medová

51 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michaela Medová Switzerland 20 650 322 197 189 165 51 1.0k
Shawna Organ Canada 8 520 0.8× 305 0.9× 226 1.1× 179 0.9× 247 1.5× 9 976
Sujatha Jagadeeswaran United States 12 465 0.7× 360 1.1× 169 0.9× 197 1.0× 89 0.5× 16 973
Hien Dang United States 15 479 0.7× 376 1.2× 92 0.5× 268 1.4× 373 2.3× 24 1.0k
JEFF EVANS United Kingdom 6 617 0.9× 397 1.2× 98 0.5× 278 1.5× 91 0.6× 24 1.2k
Gaynor Davies United Kingdom 19 576 0.9× 351 1.1× 99 0.5× 255 1.3× 203 1.2× 22 1.0k
Elizabeth A. Kuczynski Canada 12 681 1.0× 373 1.2× 203 1.0× 454 2.4× 87 0.5× 16 1.1k
Tracey Rowlands United States 10 1.0k 1.6× 595 1.8× 115 0.6× 203 1.1× 80 0.5× 14 1.4k
Mike F. Burbridge France 19 567 0.9× 250 0.8× 112 0.6× 178 0.9× 64 0.4× 33 970
Qiong Xue China 13 451 0.7× 258 0.8× 59 0.3× 309 1.6× 207 1.3× 22 872
Miriam Redrado Spain 20 544 0.8× 518 1.6× 177 0.9× 270 1.4× 47 0.3× 39 1.1k

Countries citing papers authored by Michaela Medová

Since Specialization
Citations

This map shows the geographic impact of Michaela Medová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaela Medová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaela Medová more than expected).

Fields of papers citing papers by Michaela Medová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michaela Medová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaela Medová. The network helps show where Michaela Medová may publish in the future.

Co-authorship network of co-authors of Michaela Medová

This figure shows the co-authorship network connecting the top 25 collaborators of Michaela Medová. A scholar is included among the top collaborators of Michaela Medová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michaela Medová. Michaela Medová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Medo, Matúš, Charlotte K.Y. Ng, & Michaela Medová. (2024). A comprehensive comparison of tools for fitting mutational signatures. Nature Communications. 15(1). 9467–9467. 3 indexed citations
2.
Medo, Matúš, Manja Friese‐Hamim, Si’Ana A. Coggins, et al.. (2024). E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network. Cancer Research Communications. 4(7). 1863–1880. 1 indexed citations
3.
Gao, Yanyun, Fabian Blank, Michaela Medová, et al.. (2024). Inhibition of LDHB suppresses the metastatic potential of lung cancer by reducing mitochondrial GSH catabolism. Cancer Letters. 611. 217353–217353. 4 indexed citations
4.
Aebersold, Ruedi, Deborah Stroka, Daniel M. Aebersold, et al.. (2023). A DNA-PK phosphorylation site on MET regulates its signaling interface with the DNA damage response. Oncogene. 42(26). 2113–2125. 3 indexed citations
5.
Schanne, Daniel H., Olgun Eliçin, Roland Giger, et al.. (2022). Prognostic and Predictive Biomarkers in Head and Neck Squamous Cell Carcinoma Treated with Radiotherapy—A Systematic Review. Biomedicines. 10(12). 3288–3288. 5 indexed citations
6.
Zimmer, Yitzhak, et al.. (2022). Beyond keratinocyte differentiation: emerging new biology of small proline-rich proteins. Trends in Cell Biology. 33(1). 5–8. 12 indexed citations
7.
Mélin, Nicolas, Daniel Sánchez‐Taltavull, René Fahrner, et al.. (2021). Synergistic effect of the TLR5 agonist CBLB502 and its downstream effector IL-22 against liver injury. Cell Death and Disease. 12(4). 366–366. 13 indexed citations
8.
Gazdhar, Amiq, Roberta Esposito, Carlos Pulido-Quetglas, et al.. (2021). Enhancing CRISPR deletion via pharmacological delay of DNA-PKcs. Genome Research. 31(3). 461–471. 7 indexed citations
9.
Aebersold, Daniel M., et al.. (2020). MET targeting: time for a rematch. Oncogene. 39(14). 2845–2862. 48 indexed citations
10.
Bensimon, Ariel, Paola Francica, Andree Blaukat, et al.. (2020). Deciphering MET‐dependent modulation of global cellular responses to DNA damage by quantitative phosphoproteomics. Molecular Oncology. 14(6). 1185–1206. 9 indexed citations
11.
Sánchez‐Taltavull, Daniel, Tess M. Brodie, Lilian Salm, et al.. (2020). The LIM Protein Ajuba Augments Tumor Metastasis in Colon Cancer. Cancers. 12(7). 1913–1913. 13 indexed citations
12.
Nisa, Lluís, Paola Francica, Roland Giger, et al.. (2019). Targeting the MET Receptor Tyrosine Kinase as a Strategy for Radiosensitization in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma. Molecular Cancer Therapeutics. 19(2). 614–626. 11 indexed citations
13.
Felser, Andrea, Katarzyna Pierzchała, Jean‐Marc Nuoffer, et al.. (2019). Metabolomics reveals tepotinib‐related mitochondrial dysfunction in MET‐activating mutations‐driven models. FEBS Journal. 286(14). 2692–2710. 2 indexed citations
14.
Jakob, Manuel O., Adrian Keogh, Laure C. Bouchez, et al.. (2019). Verteporfin-induced lysosomal compartment dysregulation potentiates the effect of sorafenib in hepatocellular carcinoma. Cell Death and Disease. 10(10). 749–749. 55 indexed citations
15.
Nisa, Lluís, David Barras, Michaela Medová, et al.. (2018). Comprehensive Genomic Profiling of Patient-matched Head and Neck Cancer Cells: A Preclinical Pipeline for Metastatic and Recurrent Disease. Molecular Cancer Research. 16(12). 1912–1926. 23 indexed citations
16.
Aebersold, Daniel M., et al.. (2018). The relevance of tyrosine kinase inhibitors for global metabolic pathways in cancer. Molecular Cancer. 17(1). 27–27. 39 indexed citations
17.
Francica, Paola, Lluís Nisa, Daniel M. Aebersold, et al.. (2016). Depletion of FOXM1 via MET Targeting Underlies Establishment of a DNA Damage–Induced Senescence Program in Gastric Cancer. Clinical Cancer Research. 22(21). 5322–5336. 27 indexed citations
18.
Medová, Michaela, Lluís Nisa, Paola Francica, et al.. (2015). Impact of p53 Status on Radiosensitization of Tumor Cells by MET Inhibition–Associated Checkpoint Abrogation. Molecular Cancer Research. 13(12). 1544–1553. 8 indexed citations
19.
Medová, Michaela, Bruno Streit, Paola Francica, et al.. (2013). The Novel ATP-Competitive Inhibitor of the MET Hepatocyte Growth Factor Receptor EMD1214063 Displays Inhibitory Activity against Selected MET-Mutated Variants. Molecular Cancer Therapeutics. 12(11). 2415–2424. 25 indexed citations
20.
Zimmer, Yitzhak, Angelina V. Vaseva, Michaela Medová, et al.. (2009). Differential inhibition sensitivities of MET mutants to the small molecule inhibitor SU11274. Cancer Letters. 289(2). 228–236. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shawna Organ Breakdown of academic impact, for papers by Sujatha Jagadeeswaran Breakdown of academic impact, for papers by Hien Dang Breakdown of academic impact, for papers by JEFF EVANS Breakdown of academic impact, for papers by Gaynor Davies Breakdown of academic impact, for papers by Elizabeth A. Kuczynski Breakdown of academic impact, for papers by Tracey Rowlands Breakdown of academic impact, for papers by Mike F. Burbridge Breakdown of academic impact, for papers by Qiong Xue Breakdown of academic impact, for papers by Miriam Redrado
Rankless by CCL
2026